Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing

Kun Li, Daniel Quiat, Fei She, Yuanwei Liu, Rong He, Alireza Haghighi, Fang Liu, Rui Zhang, Steven R. DePalma, Ying Yang, Wen Wang, Christine E. Seidman, Ping Zhang, Jonathan G. Seidman

Abstract

Facioscapulohumeral dystrophy type 1 (FSHD1) is a progressive, debilitating skeletal myopathy that requires a multimodal approach for complete molecular characterization of pathogenic genotypes. Here, we report genomic analyses of a family with suspected facioscapulohumeral dystrophy type 1 (FSHD1). We first performed short read genome sequencing, followed by parametric linkage analysis using rare variants to map the disease locus to a single 1.7 MB interval on chromosome 4q35.2 with a LOD score of 3.2. We then used ultra-long read genome sequencing as a single molecular test to genotype a pathogenic FSHD allele containing a 4qA permissive haplotype and 5 KpnI repeat units at the D4Z4 locus. These results demonstrate that genome-wide rare variant-based linkage analysis is a powerful tool for mapping disease loci in families and ultra-long read genome sequencing is capable of genotyping pathogenic FSHD1 alleles.

Introduction

Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) presents a unique challenge to clinical genomics. Unlike most genetic disorders caused by discrete mutations, FSHD1 is driven by a contraction of the D4Z4 macrosatellite repeat array on chromosome 4q35. While healthy individuals typically possess 11 to 100 of these 3.3-kb repeat units, FSHD1 patients carry only 1 to 10. When this contraction occurs on a specific genetic background known as the 4qA "permissive" haplotype, it leads to the toxic expression of the DUX4 gene in muscle tissue.

Traditional diagnostic methods, such as Southern blotting, are labor-intensive and require significant quantities of high-quality DNA. Furthermore, standard short-read genome sequencing (SRS) is largely ineffective at resolving this region because the 150-bp fragments are too short to span the massive, repetitive D4Z4 units. This study demonstrates a hybrid genomic approach—combining rare-variant linkage analysis with ultra-long-read sequencing—to successfully diagnose a five-generation family.

Methods

Rare-Variant Linkage Analysis

The researchers first utilized short-read sequencing data from a five-generation kindred (eight affected and two unaffected individuals). By filtering for ultra-rare single-nucleotide polymorphisms (SNPs) using the gnomAD database (frequency < 0.01%), they performed parametric linkage analysis. These rare variants served as high-resolution markers to track the inheritance of the disease-causing segment through the family tree.

Ultra-Long Read Genome Sequencing (ONT)

To resolve the repetitive structure of the D4Z4 array, the team employed Oxford Nanopore Technologies (ONT) to generate ultra-long reads. These reads averaged approximately 35,000 bp, with some exceeding 60,000 bp, allowing for the capture of multiple repeat units in a single continuous sequence.

Bioinformatic Alignment to CHM13

A critical component of the methodology was the use of the CHM13 (T2T-v2.0) reference genome. Unlike the standard hg38 reference, which contains gaps and errors in highly repetitive subtelomeric regions, the Telomere-to-Telomere (T2T) assembly provides a complete map of the 4q35.2 locus, enabling accurate alignment and counting of the D4Z4 repeats.

Results

Locus Mapping

The rare-variant linkage analysis successfully narrowed the candidate region to a 1.7 MB interval on chromosome 4q35.2. The statistical strength of this association was confirmed by a LOD score of 3.2, providing high confidence that the disease locus had been correctly identified.

Molecular Characterization of the Pathogenic Allele

Ultra-long-read sequencing provided the definitive molecular diagnosis. The analysis identified three specific reads that spanned the entire D4Z4 array of the affected individual. These reads revealed:

  1. Repeat Contraction: A 5-unit D4Z4 repeat array, falling within the pathogenic range (1–10 units).
  2. Permissive Haplotype: The presence of the 4qA haplotype, which contains the polyadenylation signal necessary for DUX4 mRNA stability and subsequent muscle toxicity.

For comparison, the researchers also identified a read from the non-pathogenic allele containing 11 repeat units, further validating the accuracy of the long-read approach.

Discussion

This study highlights the enduring utility of linkage analysis in the era of modern genomics. By leveraging ultra-rare variants as markers, researchers can effectively navigate complex pedigrees to isolate disease-causing regions.

Furthermore, the success of ultra-long-read sequencing in this case underscores the shift toward "single-molecule" diagnostics for repeat expansion and contraction disorders. By capturing the entire D4Z4 array in single reads, the ambiguity inherent in short-read assembly is eliminated. However, a significant limitation remains: the low yield of reads spanning the region of interest (only 4 out of 750,000).

Future clinical implementation will likely require enrichment strategies, such as adaptive sampling or targeted capture, to increase the depth of coverage at the 4q35.2 locus. As reference genomes like CHM13 become the standard, the ability to resolve genomic "dark matter" will continue to improve, offering clearer diagnostic paths for patients with complex muscular dystrophies.

Summary updated

Abstract

Abstract Facioscapulohumeral dystrophy type 1 (FSHD1) is a progressive, debilitating skeletal myopathy that requires a multimodal approach for complete molecular characterization of pathogenic genotypes. Here, we report genomic analyses of a family with suspected facioscapulohumeral dystrophy type 1 (FSHD1). We first performed short read genome sequencing, followed by parametric linkage analysis using rare variants to map the disease locus to a single 1.7 MB interval on chromosome 4q35.2 with a LOD score of 3.2. We then used ultra-long read genome sequencing as a single molecular test to genotype a pathogenic FSHD allele containing a 4qA permissive haplotype and 5 KpnI repeat units at the D4Z4 locus. These results demonstrate that genome-wide rare variant-based linkage analysis is a powerful tool for mapping disease loci in families and ultra-long read genome sequencing is capable of genotyping pathogenic FSHD1 alleles.
BibTeX
@inproceedings{li2024genetic,
  author = {Kun Li and Daniel Quiat and Fei She and Yuanwei Liu and Rong He and Alireza Haghighi and Fang Liu and Rui Zhang and Steven R. DePalma and Ying Yang and Wen Wang and Christine E. Seidman and Ping Zhang and Jonathan G. Seidman},
  title = {{Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing}},
  booktitle = {Genetics},
  year = {2024},
  doi = {10.1016/j.gimo.2024.101817},
}
Figure